Historic Events

Exporting Health to U.S.A. Made in Bangladesh

Beximco Pharmaceuticals Ltd. becomes the First Ever Bangladeshi Pharma Company to export Medicine to the United States of America, conforming to the highest standards of quality as set by the US FDA. This is a piece of history. Made in Bangladesh.

A remarkable feat for the company as
well as for the country′s pharma industry.

Nazmul Hassan MP, Managing Director, Beximco Pharma

I am in awe of what we've achieved today and couldn′t be more excited about the future. Pharma is extremely a knowledge driven, complex and highly regulated industry. I believe our planned initiative in line with our aspirations have largely helped us expanding our reach and take our industry to the world. We have touched the lives of millions of people around the world and we have earned that trust and confidence through our unwavering commitment to healthcare. My sincerest thanks and appreciation to everyone for your profound contribution and for being with us in our journey.

A Vision seen.
Another beckons.

Salman F Rahman, Vice Chairman, BEXIMCO Group

This is a proud moment for Beximco Pharma and also for the Pharma industry of Bangladesh. This is a remarkable achievement and I believe this will mark the beginning of a new era for our Pharma industry. We have already expanded our geographic footprint across 54 countries and much of our strategic focus is now on building and strengthening presence in the regulated markets for value added generics. In the last 45 years of our existence, we remain firm in our commitment to improve health and well being of the people by providing access to affordable medicines, and at the same time help boosting country’s economic growth through various export initiatives.

On 4 August 2016, Beximco Pharmaceuticals became the first Bangladeshi Pharmaceutical Company to export Carvedilol, a prescription medicine, to the United States of America. Every granule of every tablet bears the spirit of striving for perfection in doing and honesty in being. This achievement is as much for our national character as it is of our company’s. Come Bangladesh, let all of us celebrate this achievement. Here’s to Excellence. Here’s to perfection. Here’s to Beximco Pharma. Here’s to Bangladesh. And above all, Here’s to Life.

News Feed

Beximco Pharmaceu-ticals is expanding its footprint into the US, one of the highly regulated drug markets in the world, as it has recently received approval from the US Food and Drug Administration or FDA to sell a type 2 diabetes medicine.

Read more...

First Bangladeshi pharmaceutical company to launch pharmaceutical products in the US

Beximco Pharmaceuticals Limited (“BPL”, “Beximco Pharma” or “Company”; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces it has commenced the export of Carvedilol, a prescription drug for treating hypertension, to the US. This follows the product′s approval from the US Food and Drug Administration (“US FDA”) in November 2015 and is the first time a pharmaceutical product from Bangladesh has been launched in the US.

Read more...

Receiving approval from the United States Food and Drug Administration is a long and rigorous process. It is the FDA′s job to uphold the highest standards and to protect American consumers. It is a testament to Beximco′s hard work - as well as the quality of their products - that Bangladesh is able to celebrate the occasion of exporting the first FDA-approved drug to the United States.

Read more...

Beximco Pharmaceuticals Ltd, a fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, yesterday announced that it has started exports of Carvedilol, a prescription drug for treating hyperte.

Read more...

Beximco Pharmaceuticals on Thursday marked their first ever export of pharmaceuticals to the lucrative US market by sending a shipment of Carvedilol, a prescription drug for treating hypertension. In November last year the US Food and Drug Administration (FDA) approved Bangladesh′s largest exporter of pharmaceuticals to sell its products in the US.

Read more...

Beximco Pharmaceuticals Ltd said on Thursday they had commenced the export of hypertensive drug, Carvedilol, and became the first Bangladeshi company to enter the stringent market regulated by the Food and Drug Administration (FDA).

Read more...

Beximco Pharmaceuticals yesterday announced its first export of medicines to the United States, one of the most regulated drug markets in the world. It shipped out Carvedilol, a prescription drug to treat hypertension. This is the first time a pharmaceutical product made in Bangladesh has hit the American market.

Read more...

Beximco Pharmaceuticals Limited has become the first Bangladeshi pharmaceutical company to receive approval for a prescription drug to be manufactured in the country for export to the USA. The company has been granted formal approval from the US Food and Drug Administration (US FDA), following an extensive review of the submitted dossier and its manufacturing processes, said a press release.

Read more...

Beximco Pharmaceuticals Limited (BPL) will manufacture blood pressure drug Carvedilol as it has received US FDA approval, to produce and export the medicine to the United States of America (USA). The BPL says it has been granted formal approval from the US Food and Drug Administration (US FDA), following an extensive review of the submitted dossier and its manufacturing processes.

Read more...

Beximco Pharmaceuticals Limited is set to export medicines to the United States from today as part of its initiative to focus its presence in many emerging and developing markets in the world. Marking the occasion, BPL is set to organise a function in Le Meridian Hotel, said a press release Wednesday.

Read more...